What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?
- PMID: 21454199
- PMCID: PMC7020666
- DOI: 10.3816/CLML.2011.n.015
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?
Abstract
Population-based studies suggest a role for chronic immune stimulation and genetic factors in the causation of lymphoplasmacytic lymphoma (LPL)/Waldenström's macroglobulinemia (WM). In this review we summarize and discuss our current understanding on etiology and pathogenesis of LPL/WM. We also highlight on gaps in the literature and propose future directions for population-based and molecular studies designed to expand our knowledge and uncover biological underpinnings of identified associations. Further, we address clinical implications and provide perspective on the relevance of these data for patient counseling and clinical follow-up.
Conflict of interest statement
Conflict of Interest Statement
The authors have no conflict of interest to declare.
Similar articles
-
Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.Clin Lymphoma Myeloma. 2009 Mar;9(1):23-6. doi: 10.3816/CLM.2009.n.004. Clin Lymphoma Myeloma. 2009. PMID: 19362964 Free PMC article. Review.
-
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):194-7. doi: 10.1016/j.clml.2013.02.002. Epub 2013 Mar 7. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23473950 Free PMC article. Review.
-
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710. N Engl J Med. 2012. PMID: 22931316
-
[Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].Rinsho Ketsueki. 2021;62(8):1139-1148. doi: 10.11406/rinketsu.62.1139. Rinsho Ketsueki. 2021. PMID: 34497201 Review. Japanese.
-
L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.PLoS One. 2013 Nov 5;8(11):e80088. doi: 10.1371/journal.pone.0080088. eCollection 2013. PLoS One. 2013. PMID: 24224040 Free PMC article.
Cited by
-
Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects.Ann Hematol. 2024 Jun;103(6):1859-1876. doi: 10.1007/s00277-023-05345-9. Epub 2023 Jul 6. Ann Hematol. 2024. PMID: 37414960 Review.
-
Waldenström macroglobulinemia: biology, genetics, and therapy.Blood Lymphat Cancer. 2016 Jul 26;6:49-58. doi: 10.2147/BLCTT.S84157. eCollection 2016. Blood Lymphat Cancer. 2016. PMID: 31360080 Free PMC article. Review.
-
Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.Curr Treat Options Oncol. 2016 Mar;17(3):16. doi: 10.1007/s11864-016-0391-7. Curr Treat Options Oncol. 2016. PMID: 26942591 Review.
-
Waldenström Macroglobulinemia: Review of Pathogenesis and Management.Clin Lymphoma Myeloma Leuk. 2017 May;17(5):252-262. doi: 10.1016/j.clml.2017.02.028. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28366781 Free PMC article. Review.
-
Biclonal lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with POEMS syndrome: A case report and literature review.Oncol Lett. 2023 Jan 27;25(3):97. doi: 10.3892/ol.2023.13683. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36817054 Free PMC article.
References
-
- Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia. Semin Oncol 2003; 30:110–5. - PubMed
-
- Bjorkholm M Lymphoplasmacytic Lymphoma/Waldenstrom’s Macroglobulinemia In: Canellos G, Lister A, Young B, eds. The Lymphomas (2d ed). Philadelphia: W.B. Saunders, 2006:374–80.
-
- Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni JF Jr. Waldenstrom’s macroglobulinemia: incidence patterns in the United States, 1988–1994. Cancer 1998; 82:1078–81. - PubMed
-
- Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102:3759–64. - PubMed
-
- Aoki H, Takishita M, Kosaka M, Saito S. Frequent somatic mutations in D and/ or JH segments of Ig gene in Waldenstrom’s macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter’s syndrome but not in common CLL. Blood 1995; 85:1913–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources